Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

cAMPS-Rp, triethylammonium salt, Tocris Bioscience™

Catalog Number 13371
Click to view available options
Quantity:
1 mg
This item is not returnable. View return policy
151837-09-1
C16H27N6O5PS
446.463
OXIPZMKSNMRTIV-NVGWRVNNSA-N
camps-rp, triethylammonium salt, camps-sp, triethylammonium salt, s-adenosine, cyclic 3',5'-hydrogenphosphorothioate triethylammonium, r-adenosine, cyclic 3',5'-hydrogenphosphorothioate triethylammonium
90479783
(4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol;triethylazanium
CC[NH+](CC)CC.C1C2C(C(C(O2)N3C=NC4=C3N=CN=C4N)O)OP(=S)(O1)[O-]
This item is not returnable. View return policy
151837-09-1
C16H27N6O5PS
446.463
OXIPZMKSNMRTIV-NVGWRVNNSA-N
camps-rp, triethylammonium salt, camps-sp, triethylammonium salt, s-adenosine, cyclic 3',5'-hydrogenphosphorothioate triethylammonium, r-adenosine, cyclic 3',5'-hydrogenphosphorothioate triethylammonium
90479783
(4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol;triethylazanium
CC[NH+](CC)CC.C1C2C(C(C(O2)N3C=NC4=C3N=CN=C4N)O)OP(=S)(O1)[O-]

cAMP antagonist

Cell-permeable cAMP analog; acts as a competitive antagonist of cAMP-induced activation of PKA (IC50 = 11 - 16 μM) by interacting with cAMP binding sites on the regulatory subunits. Resistant to hydrolysis by phosphodiesterases.
Quantity 1 mg
Formula Weight 446.46
Percent Purity >98%
Chemical Name or Material cAMPS-Rp, triethylammonium salt
Recommended Storage Desiccate at -20°C
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit